NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Real-World Study of Ceftazidime Avibactam in China

TerminatedN/A

Sponsor: Pfizer

Conditions: Hospital Acquired Pneumonia, Ventilator Acquired Pneumonia, Complicated Intra Abdominal Infections

Interventions: ceftazidime avibactam group

Countries: China

This observational study will enroll approximately 450 in patients. Patients treated with CAZ AVI for at least 1 dose at around 20 research centers in China will be enroll.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion criteria：

* Initiate ≥1 dose of ceftazidime-avibactam during hospitalization.
* Aged ≥ 18 years old at the time of the informed consent signature.
* Provide signed informed consent. Exclusion criteria：
* Are enrolled in any clinical trial, including enrollment in non interventional studies.
* Pregnant women.

Locations (17)

Shanghai, Shanghai Municipality, China
Beijing, China
Changsha, China
Guangzhou, China
Hangzhou, China
Hangzhou, China
Hefei, China
Nanchang, China
Nanjing, China
Ningbo, China
Shanghai, China
Shijiazhuang, China
Shijiazhuang, China
Suzhou, China
Tianjing, China
Xi'an, China
Zhengzhou, China